Four things to know:
1. Mitias Orthopaedics in New Albany, Miss., allegedly billed for a name-brand injectable knee device but actually used a cheaper product from a compound pharmacy.
2. A former pharmaceutical sales rep filed a qui tam lawsuit against the practice, alleging it violated the False Claims Act by receiving reimbursement for the name-brand injectable while using the cheaper product to increase profits.
3. The U.S. government has decided to intervene in the case, and the whistleblower stands to receive a portion of any funds recovered.
4. The lawsuit was filed in the U.S. Court for the Northern District of Mississippi.
More articles on orthopedic surgeons:
9 orthopedic surgeons on the move in January
How total joints’ outpatient migration could affect value-based pay
Rothman orthopedic surgeon appointed medical director of ValueHealth
